Korean Circ J.  2022 Aug;52(8):621-622. 10.4070/kcj.2022.0166.

Protein-losing Enteropathy: A Big Challenge in Fontan Circulation

• Lee JY

• KMID: 2532332
• DOI: http://doi.org/10.4070/kcj.2022.0166

Reference

1. Rychik J, Atz AM, Celermajer DS, et al. Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation. 2019; 140:CIR0000000000000696.

2. Yoon JK, Kim GB, Song MK, et al. Long-term outcome of Fontan-associated protein-losing enteropathy: treatment modality and predictive factor of mortality. Korean Circ J. 2022; 52:606–620.

3. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg. 1998; 115:1063–1073. PMID: 9605076.

4. John AS, Johnson JA, Khan M, Driscoll DJ, Warnes CA, Cetta F. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol. 2014; 64:54–62. PMID: 24998129.

5. Schleiger A, Ovroutski S, Peters B, et al. Treatment strategies for protein-losing enteropathy in Fontan-palliated patients. Cardiol Young. 2020; 30:698–709. PMID: 32364090.

6. Sharma VJ, Iyengar AJ, Zannino D, et al. Protein-losing enteropathy and plastic bronchitis after the Fontan procedure. J Thorac Cardiovasc Surg. 2021; 161:2158–2165.e4. PMID: 32928546.